Clinical trial Recruiting at 1 site Interventional Ages 35 to 75 Women only

Bupivacaine to reduce pain after laparoscopic hysterectomy

Official title: Effect of Trocar Site and Vaginal Cuff Bupivacaine Injection on Postoperative Pain in Patients Undergoing Total Laparoscopic Hysterectomy

Run by Gaziosmanpasa Research and Education Hospital · NCT07435909 · Data updated 2026-11-12

This trial will test whether injecting 0.5% bupivacaine around the trocar sites and into the vaginal cuff at the end of a laparoscopic hysterectomy reduces early postoperative pain for women having the operation for benign conditions.

More Postoperative Pain trials

Quick facts

Study typeInterventional
Ages35 Years to 75 Years
SexWomen only
Enrollment120 (estimated)
SponsorGaziosmanpasa Research and Education Hospital
Government
Locations1 site (Istanbul, Gaziosmanpaşa)
StatusRecruiting
StartedAugust 28, 2025
Main results expectedJune 4, 2026
Study endsJune 4, 2026
Registry record updatedMay 27, 2026
Trial IDNCT07435909 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 35–75 scheduled for total laparoscopic hysterectomy for benign gynecologic conditions, ASA class I–II, cognitively able to report pain, and who complete the surgery laparoscopically are the intended participants.

Probably not a fit

Patients with suspected or confirmed malignant gynecologic disease, known allergy to bupivacaine, chronic pain syndromes or analgesic dependence, or those converted to laparotomy are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, randomized, single-blind controlled trial comparing intraoperative local infiltration of 0.5% bupivacaine at trocar entry sites and the vaginal cuff with no local anesthetic injection in patients undergoing total laparoscopic hysterectomy for benign indications. All participants receive standard postoperative analgesia while pain is measured with a visual analog scale at 1, 2, 3, 6, 12 and 24 hours after surgery. Secondary outcomes include additional analgesic requirements, time to first mobilization, time to first flatus, and length of hospital stay. The intervention delivers a total of 10 mL (5 mL 0.5% bupivacaine diluted with 5 mL saline) with targeted injections under laparoscopic visualization.

Why it matters

Potential benefit: If successful, the approach could reduce early postoperative pain and opioid use, helping patients mobilize and recover sooner.

How similar studies have gone: Previous studies of trocar-site infiltration with local anesthetic have reported mixed results, and combined trocar-site plus vaginal cuff infiltration is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Female patients aged 35-75 years
* Scheduled for total laparoscopic hysterectomy for benign gynecologic conditions, including leiomyoma uteri, adenomyosis, abnormal uterine bleeding, endometrial pathology (non-atypical hyperplasia, endometrial thickening, or polyps), cervical intraepithelial lesions (CIN 2-3) without evidence of invasion and indicated for therapeutic hysterectomy, chronic pelvic pain, or benign uterine prolapse
* American Society of Anesthesiologists (ASA) physical status class I-II
* Cognitive ability sufficient to assess and report postoperative pain (no dementia or severe psychiatric disorder)
* Provision of written informed consent
* Completion of surgery laparoscopically as planned (no conversion to laparotomy)

Exclusion Criteria:

* Presence or suspicion of malignant gynecologic disease
* History of allergy or hypersensitivity to bupivacaine or other amide-type local anesthetics
* History of chronic pain syndrome, analgesic dependence, or regular use of opioids or nonsteroidal anti-inflammatory drugs (NSAIDs)
* Severe systemic disease (e.g., uncontrolled diabetes mellitus, hepatic or renal insufficiency, or heart failure)
* Neurological or psychiatric disorders that impair the ability to assess or report pain

Where it's running

  • SBÜ Gaziosmanpaşa Training and Research Hospital
    Istanbul, Gaziosmanpaşa, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.